Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 289, Issue 5 52-5, 2005, Pages

  Grefhorst, Aldo ^a   Van Dijk, Theo H ^a   Hammer, Anke ^a   Van Der Sluijs, Fjodor H ^a   Havinga, Rick ^a   Havekes, Louis M ^b   Romijn, Johannes A ^b   Groot, Pieter H ^c   Reijngoud, Dirk Jan ^a   Kuipers, Folkert ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Hepatic glucose production; Hepatic steatosis; Hyperinsulinemic euglycemic clamp; Stable isotopes; Triglycerides

Indexed keywords

CELL NUCLEUS RECEPTOR; LIVER X RECEPTOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FATTY LIVER; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HYPERINSULINEMIA; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIVER PARENCHYMA; METABOLIC CLEARANCE RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT;

ACETYLTRANSFERASES; ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD95; BENZOIC ACIDS; BENZYLAMINES; BLOOD GLUCOSE; DNA-BINDING PROTEINS; FATTY ACIDS; GENE EXPRESSION; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORTER TYPE 4; INSULIN; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRIGLYCERIDES;

EID: 25444512015     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00165.2005     Document Type: Article

References (47)

1. Abu-Elheiga L, Matzuk MM, Abo-Hashema KAH, and Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-coa carboxylase 2. Science 291: 2613-2616, 2001.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231, 2002.
3. Bandsma RHJ, Grefhorst A, van Dijk TH, van der Sluijs FH, Hammer A, Reijngoud DJ, and Kuipers F. Enhanced glucose cycling and suppressed de novo synthesis of glucose-6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice. Diabetologia 47: 2022-2031, 2004.
4. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, and Hobbs HH. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290: 1771-1775, 2000.
5. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
6. Böttcher CFJ, van Gent CM, and Pries C. A rapid and sensitive sub-micro-phosphorus determination. Anal Chim Acta 24: 203-204, 1961.
7. Cao G, Liang Y, Broderick CL, Oldham BA, Beyer TP, Schmidt RJ, Zhang Y, Stayrook KR, Suen C, Otto KA, Miller AR, Dai J, Foxworthy P, Gao H, Ryan TP, Jiang XC, Burris TP, Eacho PI, and Etgen GJ. Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. J Biol Chem 278: 1131-1136, 2003.
8. Chisholm JW, Hong J, Mills SA, and Lawn RM. The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. J Lipid Res 44: 2039-2048, 2003.
9. Costet P, Luo Y, Wang N, and Tall AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 275: 28240-28245, 2000.
10. Davis RA and Hui TY. 2000 George Lyman Duff Memorial Lecture. Atherosclerosis is a liver disease of the heart. Arterioscler Thromb Vasc Biol 21: 887-898, 2001.
11. Den Boer M, Voshol PJ, Kuipers F, Havekes LM, and Romijn JA. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arterioscler Thromb Vasc Biol 24: 644-649, 2004.
12. Glass CK. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev 15: 391-407, 1994.
13. Grefhorst A, Elzinga BM, Voshol PJ, Plösch T, Kok T, Bloks VW, van der Sluijs FH, Havekes LM, Romijn JA, Verkade HJ, and Kuipers F. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipopoprotein particles. J Biol Chem 277: 34182-34190, 2002.
14. Gupta S, Pandak WM, and Hylemon PB. LXRalpha is the dominant regulator of CYP7A1 transcription. Biochem Biophys Res Commun 293: 338-343, 2002.
15. Hellerstein MK, Neese RA, Linfoot P, Christiansen M, Turner S, and Letscher A. Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study. J Clin Invest 100: 1305-1319, 1997.
16. Hohorst HJ. D-Glucose-6-phosphat und D-fructose-6-phosphat. In: Methoden der Enzymatischen Analyse, edited by Bergmeyer HU. Weinheim, Germany: Verlag Chemie, 1970, p. 1200-1204.
17. Juvet LK, Andresen SM, Schuster GU, Dalen KT, Tobin KAR, Hollung K, Haugen F, Jacinto S, Ulven SM, Bamberg K, Gustafsson JA, and Nebb HI. On the role of liver X receptors in lipid accumulation in adipocytes. Mol Endocrinol 17: 172-182, 2003.
18. Keppler D and Decker K. Glykogen. Bestimmung mit amyloglucosidase. In: Methden der Enzymatischen Analyse, edited by Bergmeyer HU. Weinheim, Germany: Verlag Chemie, 1970, p. 1089-1094.
19. Kim SY, Kim H, Kim TH, Im SS, Park SK, Lee IK, Kim KS, and Ahn YH. SREBP-1c mediates the insulin-dependent hepatic glucokinase expression. J Biol Chem 279: 30823-30829, 2004.
20. Kuipers F, Havinga R, Bosschieter H, Toorop GP, Hindriks FR, and Vonk RJ. Enterohepatic circulation in the rat. Gastroenterology 88: 403-411, 1985.
21. Kumar KS and Malet PF. Nonalcoholic steatohepatitis. Mayo Clin Proc 75: 733-739, 2000.
22. Laffitte BA, Chao LS, Li J, Walczak R, Hummasti S, Joseph SB, Castrillo A, Wilpitz DC, Mangelsdorf DJ, Collins JL, Saez E, and Tontonoz P. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci USA 100: 5419-5424, 2003.
23. Laffitte BA, Repa JJ, Joseph SB, Wilpitz DC, Kast HR, Mangelsdorf DJ, and Tontonoz P. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci USA 98: 507-512, 2001.
24. Lee WN, Byerley LO, Bergner EA, and Edmond J. Mass isotopomer analysis: theoretical and practical considerations. Biol Mass Spectrom 20: 451-458, 1991.
25. Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA, and Willson TM. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 272: 3137-3140, 1997.
26. Lepage G and Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27: 114-120, 1986.
27. Lowry OH, Rosenbrough NJ, Farr AL, and Randall RJ. Protein measurement with Folin-phenol reagent. J Biol Chem 193: 265-275, 1951.
28. Magnuson MA, She P, and Shiota M. Gene-altered mice and metabolic flux control. J Biol Chem 278: 32485-32488, 2003.
29. Millatt LJ, Bocher V, Fruchart JC, and Staels B. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis. Biochim Biophys Acta 1631: 107-118, 2003.
30. Miyazaki M and Ntambi JM. Role of stearoyl-coenzyme A desaturase in lipid metabolism. Prostaglandins Leukot Essent Fatty Acids 68: 113-121, 2003.
31. Orci L, Cook WS, Ravazzola M, Wang M, Park BH, Montesano R, and Unger RH. Rapid transformation of white adipocytes into fat-oxidizing machines. Proc Natl Acad Sci USA 101: 2058-2063, 2004.
32. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JMA, Hammer RE, and Mangelsdorf DJ. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα. Cell 93: 693-704, 1998.
33. Plösch T, Kok T, Bloks VW, Smit MJ, Havinga R, Chimini G, Groen AK, and Kuipers F. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J Biol Chem 277: 33870-33877, 2002.
34. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, and Mangelsdorf DJ. Regulation of ATP-binding cassette sterol transporters, ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 2002.
35. Repa JJ, Turley SD, Lobaccaro JMA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, and Mangelsdorf DJ. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289: 1524-1529, 2000.
36. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, Lustig KD, and Shan B. Role of LXR in control of lipogenesis. Genes Dev 14: 2831-2838, 2000.
37. Schwartz K, Lawn RM, and Wade DP. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem Biophys Res Commun 274: 794-802, 2000.
38. Stulnig TM, Steffensen KR, Gao H, Reimers M, Dahlman-Wright K, Schuster GU, and Gustafsson JA. Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue. Mol Pharmacol 62: 1299-1305, 2002.
39. Teboul M, Enmark E, Li Q, Wikström AC, Pelto-Huikko M, and Gustafsson JA. OR-1, a member of the nuclear superfamily that interacts with the 9-cis-retinoic acid receptor. Proc Natl Acad Sci USA 92: 2096-2100, 1995.
40. Terasaka N, Hiroshima A, Koieyama T, Ubukata N, Morikawa Y, Nakai D, and Inaba T. T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice. FEBS Lett 536: 6-11, 2003.
41. Van Dijk TH, Boer TS, Havinga R, Stellaard F, Kuipers F, and Reijngoud DJ. Quantification of hepatic carbohydrate metabolism in conscious mice using serial blood and urine spots. Anal Biochem 322: 1-13, 2003.
42. Van Dijk TH, van der Sluijs FH, Wiegman CH, Baller JFW, Gustafson LA, Burger HJ, Herling AW, Kuipers F, Meijer AJ, and Reijngoud DJ. Acute inhibition of hepatic glucose-6-phosphate does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats. J Biol Chem 276: 25727-25735, 2001.
43. Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, and Tontonoz P. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα. Proc Natl Acad Sci USA 97: 12097-12102, 2000.
44. Venkateswaran A, Repa JJ, Lobaccaro JMA, Bronson A, Mangelsdorf DJ, and Edwards PA. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J Biol Chem 275: 14700-14707, 2000.
45. Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nälsén C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson IB, and Storlien LH. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia 44: 312-319, 2001.
46. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, and Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9: 1033-1045, 1995.
47. Yu L, York J, von Bergmann K, Lutjohann D, Cohen JC, and Hobbs HH. Stimulation of cholesterol excretion by LXR agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem 278: 15565-15570, 2003.